A fast and easy way to find out about all new FDA approved cancer treatments.
Monday, October 22, 2012
Alimta maintenance for NSCLC
Alimta now approved as maintenance therapy every 3 weeks after completion of combination therapy with cisplatin for locally advanced or metastatic non-squamous non-small cell lung cancer.
No comments:
Post a Comment